Amanda E. Aung

Amanda E. Aung serves as a key procurement professional within the National Cancer Institute, supporting the agency’s mission to accelerate breakthroughs in cancer research through strategic acquisition of scientific and technical services. She manages a portfolio of research and development contracts focused on advancing biomedical innovation, including experimental therapies, diagnostic platforms, and translational science initiatives. Her work ensures that cutting-edge scientific capabilities are rapidly integrated into the NCI’s research ecosystem, aligning procurement decisions with national priorities in precision medicine and oncology innovation. Aung maintains a consistent working relationship with Quality Biological, Inc., a trusted vendor specializing in high-purity biological reagents and research-grade materials essential for preclinical and clinical investigations. Her contracting patterns reflect long-term, mission-critical partnerships with vendors capable of delivering compliant, high-integrity biological products under stringent regulatory standards. These relationships are built on technical reliability, quality assurance, and adherence to Good Laboratory Practices, enabling seamless support for NCI-funded laboratories and clinical trials. Aung’s procurement strategy reflects a firm commitment to open competition, with 100% of her acquisitions conducted under non-set-aside authorities. She does not utilize socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs, instead prioritizing technical capability and scientific suitability as the primary selection criteria. This approach ensures that the most qualified providers—regardless of business size or certification—are selected to meet the NCI’s demanding research requirements. Her primary focus lies within NAICS 541715, encompassing research and development in the life sciences. She routinely procures specialized services including in vitro assay development, biomarker validation, animal model characterization, and analytical chemistry support. Her domain expertise centers on the procurement of reagents, biological standards, and research infrastructure critical to cancer biology, immunotherapy, and genomic profiling initiatives.